90 research outputs found
Outbreak of methicillin-resistant <em>Staphylococcus pseudintermedius</em> in a litter of puppies:evidence of vertical perinatal and horizontal transmission
Atypical ductal hyperplasia: Our experience in the management and long term clinical follow-up in 71 patients
Abstract Introduction Atypical ductal hyperplasia (ADH) is a high-risk benign lesion found in approximately 1â10% of breast biopsies and associated with a variable incidence of carcinoma after surgical excision. The main goal of our study is to present our experience in the management and long-term follow-up of 71 patients with ADH diagnosed on breast biopsy. Materials and methods Results of 3808 breast biopsy specimens from 1 January 2000 to 31 December 2005 were analyzed to identify all biopsies which resulted in a diagnosis of ADH. The histopathological results of the 45 patients who underwent surgery were analyzed. Long-term follow-up for the remaining patients was carried out. Results 45 of 71 (63.4%) patients with histological diagnosis of ADH on breast biopsy underwent surgery. Definitive histological results revealed invasive carcinoma in 7 cases (15.6%), high grade Ductal Carcinoma in situ (DCIS) in 10 (22.2%) patients, Lobular Carcinoma in situ (LCIS) in 4 cases (8.9%) and benign findings in 24 cases (53.3%). 12 of 71 (16.9%) patients underwent only long term follow-up; one (8,3%) of these developed invasive breast carcinoma after 6 years. Conclusion Atypical ductal hyperplasia diagnosed on breast biopsy is associated with a relatively high incidence of invasive carcinoma and high grade ductal carcinoma in situ at the time of surgical excision. Certain radiological and cytological criteria can be used to help determine which patients should forgo surgery and be followed up with good results. Long term follow-up is always crucial for patients who have not undergone surgery
Wireless ultrasound-guided vacuum-assisted breast biopsy: Experience in clinical practice at European Institute of Oncology
In the last few years, ultrasound-guided vacuum-assisted breast biopsy (US-VABB) has replaced surgical biopsy due to higher diagnostic accuracy and lower patient discomfort, and, at present, an even greater possibility is represented by the new wireless ultrasound-guided VAB device (Wi-UVAB). The purpose of our study is to determine the diagnostic accuracy of this new device in a sizeable representative number of patients. From January 2014 to June 2018, 168 biopsies were performed in our institution using the new Wi-UVAB device. We analyzed sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy of biopsies obtained with the new device using surgical results as reference point, following patients for at least one year. In our cohort, we obtained a complete sensitivity of 97.5%, an absolute sensitivity of 94.3%, a complete specificity of 98%, and an absolute specificity of 98%. The positive predictive value of the procedure was 97.5% while the negative predictive value was 98%. The diagnostic accuracy was 98%. The Wi-UVAB is a safe procedure with high diagnostic accuracy, comparable to that of the traditional vacuum-assisted breast biopsy and even higher than that of core needle biopsy (CNB). Moreover, the Wi-UVAB is easy to use and shows low costs as core needle biopsy (CNB)
Fulminant septic shock caused by Capnocytophaga canimorsus in Italy: Case report
Capnocytophaga canimorsus infection was recently recognized as a zoonosis. We report the first case of fulminant septic shock in Italy caused by this pathogen. The patient, with a history of splenectomy, died at the main hospital in Brescia with a presumptive diagnosis of sepsis. PCR and sequencing on post mortem samples confirmed C. canimorsus as a causative organism. Our purpose is to alert medical professionals to the virulence of C. canimorsus in asplenic and immunocompromised patients. Keywords: Capnocytophaga canimorsus, septic shock, PCR, sequencin
Reply Platelet Reactivity Is Preferred Over Genotyping in Monitoring Efficacy of Antiplatelet Therapy
Atypical Ductal Hyperplasia after Vacuum-Assisted Breast Biopsy: Can We Reduce the Upgrade to Breast Cancer to an Acceptable Rate?
(1) Background: to evaluate which factors can reduce the upgrade rate of atypical ductal hyperplasia (ADH) to in situ or invasive carcinoma in patients who underwent vacuum-assisted breast biopsy (VABB) and subsequent surgical excision. (2) Methods: 2955 VABBs were reviewed; 141 patients with a diagnosis of ADH were selected for subsequent surgical excision. The association between patients' characteristics and the upgrade rate to breast cancer was evaluated in both univariate and multivariate analyses. (3) Results: the upgrade rates to ductal carcinoma in situ (DCIS) and invasive carcinoma (IC) were, respectively, 29.1% and 7.8%. The pooled upgrade rate to DCIS or IC was statistically lower at univariate analysis, considering the following parameters: complete removal of the lesion (p-value < 0.001); BIRADS †4a (p-value < 0.001); size of the lesion â€15 mm (p-value: 0.002); age of the patients <50 years (p-value: 0.035). (4) Conclusions: the overall upgrade rate of ADH to DCIS or IC is high and, as already known, surgery should be recommended. However, ADH cases should always be discussed in multidisciplinary meetings: some parameters appear to be related to a lower upgrade rate. Patients presenting these parameters could be strictly followed up to avoid overtreatment
Bacterial and fungal superinfections are detected at higher frequency in critically ill patients affected by SARS CoVâ2 infection than negative patients and are associated to a worse outcome
COVID-19 And Breast Fine Needle Aspiration Cytology Method: What Should We Change?
Air-dried slide preparation for fine needle aspiration cytology procedures, is currently considered unsafe because of the risk of infectious aerosols of Coronavirus 19. This study compares the safety and accuracy of two different protocols, one with and one without air-dried slides
Deep Broadband Observations of the Distant Gamma-ray Blazar PKS 1424+240
We present deep VERITAS observations of the blazar PKS 1424+240, along with
contemporaneous Fermi Large Area Telescope, Swift X-ray Telescope and Swift UV
Optical Telescope data between 2009 February 19 and 2013 June 8. This blazar
resides at a redshift of , displaying a significantly attenuated
gamma-ray flux above 100 GeV due to photon absorption via pair-production with
the extragalactic background light. We present more than 100 hours of VERITAS
observations from three years, a multiwavelength light curve and the
contemporaneous spectral energy distributions. The source shows a higher flux
of (2.1) ph ms above 120 GeV in 2009 and
2011 as compared to the flux measured in 2013, corresponding to
(1.02) ph ms above 120 GeV. The measured
differential very high energy (VHE; GeV) spectral indices are
3.80.3, 4.30.6 and 4.50.2 in 2009, 2011 and 2013,
respectively. No significant spectral change across the observation epochs is
detected. We find no evidence for variability at gamma-ray opacities of greater
than , where it is postulated that any variability would be small and
occur on longer than year timescales if hadronic cosmic-ray interactions with
extragalactic photon fields provide a secondary VHE photon flux. The data
cannot rule out such variability due to low statistics.Comment: ApJL accepted March 17, 201
- âŠ